Drug Combo Improved Survival For Women With Triple-Negative Breast Cancer
byCOVID-19-
Researchers may have identified a new effective treatment regimen for patients with metastatic triple-negative breast cancer (TNBC). A clinical trial found that a monoclonal antibody medication a chemotherapy drug may significantly improve survival.
Researchers may have identified a new effective treatment regimen for patients with metastatic triple-negative breast cancer (TNBC). A clinical trial found that a monoclonal antibody medication a chemotherapy drug may significantly improve survival.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.